» Articles » PMID: 24327039

Pruritus in the Older Patient: a Clinical Review

Overview
Journal JAMA
Specialty General Medicine
Date 2013 Dec 12
PMID 24327039
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Pruritus is a common problem among elderly people and, when severe, causes as much discomfort as chronic pain. Little evidence supports pruritus treatment, limiting therapeutic possibilities and resulting in challenging management problems.

Objectives: To present the evidence on the etiology, diagnosis, and treatment of pruritus in the elderly and, using the best available evidence, provide an approach for generalist physicians caring for older patients with pruritus.

Evidence Review: PubMed and EMBASE databases were searched (1946-August 2013).The Cochrane Database of Systematic Reviews and the Agency for Healthcare Research and Quality Systematic Review Data Repository were also searched from their inception to August 2013. References from retrieved articles were evaluated.

Findings: More than 50% of elderly patients have xerosis (dry skin). Xerosis treatment should be included in the initial therapy for pruritus in all elderly patients. Calcium channel blockers and hydrochlorothiazide are important causes of pruritic skin eruptions in older patients. Neuropathic pruritus is infrequently considered but may cause localized itching (especially in the genital area) and generalized truncal pruritus (especially in patients with diabetes mellitus). Certain skin conditions are more common in elderly patients, including scabies, bullous pemphigoid, transient acantholytic dermatosis, and mycosis fungoides, and should be considered in elderly patients with pruritus.

Conclusions And Relevance: It is important to evaluate elderly patients for dermatological, systemic, and neurological etiologies of itch. A simple-to-apply diagnostic and therapeutic algorithm can be used. Xerosis, drug reactions, and neuropathy should be considered when evaluating pruritus.

Citing Articles

Effects and safety of acupuncture versus non-penetrating sham acupuncture for senile pruritus: Rationale and design for a randomized controlled trial.

Chen H, Liu S, Gao S, Yi J, Shi H, Fang J Contemp Clin Trials Commun. 2025; 44:101454.

PMID: 40027278 PMC: 11872407. DOI: 10.1016/j.conctc.2025.101454.


Topical Medications for Chronic Itch in Older Patients: Navigating a Pressing Need.

Bartley B, Pierce C, Hivnor C, Valdes-Rodriguez R Drugs Aging. 2025; 42(3):213-233.

PMID: 39883297 DOI: 10.1007/s40266-024-01174-1.


Pruritus prevalence and characteristics in Care and Treatment Facility and Geriatric Outpatient Clinic patients: a cross-sectional study using a standardized pruritus questionnaires.

Mazan P, Lesiak A, Skibinska M, Rynkowska-Kidawa M, Bednarski I, Sobolewska-Sztychny D Postepy Dermatol Alergol. 2024; 41(5):463-472.

PMID: 39606603 PMC: 11589644. DOI: 10.5114/ada.2024.144478.


Prevalence of pruritus in the elderly in an outpatient dermatologic clinic: a monocentric pilot study.

Javor S, Priano L, Anonide A, Massone C Dermatol Reports. 2024; 16(2):9778.

PMID: 38957626 PMC: 11216144. DOI: 10.4081/dr.2023.9778.


A potential new treatment with upadacitinib for acquired reactive perforating collagenosis.

Ding W, Wang Y, Song L, Zhou N JAAD Case Rep. 2024; 48:112-114.

PMID: 38813063 PMC: 11134568. DOI: 10.1016/j.jdcr.2024.04.017.